Efficacy and Safety of Continuous Versus Intermittent Linezolid Infusion in Critically Ill Patients With Septic Shock

Shock Indices Use for Early Mortality From Septic Shock

NCT05088109 ·Status: UNKNOWN

Use of Dobutamine in Patients With Sepsis and Maintained Hypoperfusion After Initial Volemic Resuscitation.

NCT05953142 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Continuous Spinal Anesthesia Versus General Anesthesia in Sepsis

NCT05897151 ·Status: UNKNOWN ·Phase: PHASE4

Impact of Low Dose Ketamine Infusion in Septic Patient on Non-invasive Estimators of ICP

NCT05149586 ·Status: COMPLETED

Ketamine Versus Low Dose Thiopental for Induction of Anesthesia in Septic Shock

NCT03104140 ·Status: COMPLETED ·Phase: PHASE3

The Efficacy of Adjunctive Use of Ondansetron in Patients With Sepsis and Septic Shock

NCT05402553 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Evaluating the Effect of Chronic Antihypertensive Therapy on Vasopressor Dosing in Septic Shock

NCT02884011 ·Status: COMPLETED

Safety and Efficacy of Extracorporeal Cytokine Hemoadsorption in Septic Shock in Critically Ill Cirrhotics

NCT03866083 ·Status: UNKNOWN ·Phase: NA

Impact of qSOFA Calculation on the Timing of Antimicrobial Therapy in the Emergency Department

NCT03299894 ·Status: COMPLETED ·Phase: NA

Septic Shock-induced Immunosuppression

NCT04067674 ·Status: RECRUITING

Gender-based Differences in the Outcome of the Treatment of Persistent Septic Shock With Hydrocortisone

NCT06537180 ·Status: COMPLETED

Interstitial Fluid Composition in Patients With Septic Versus Non-septic Shock: an Exploratory Pilot Study

NCT05039151 ·Status: COMPLETED

Empiric Antibiotic Treatment for Septic Patients in the Intensive Care Unit

NCT05924126 ·Status: RECRUITING

Evaluation of Parameters Collected From Routine Data for the Diagnosis of Sepsis and Septic Shock and Their Influence on Time to Diagnosis and Patient Outcome

NCT05383963 ·Status: RECRUITING

Immunomodulatory Properties of Ketamine in Sepsis

NCT01089361 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Does the Time Between the End of Vascular Filling and Evaluation of Its Effectiveness Modify Fluid Challenge Results in Septic Shock?

NCT02116413 ·Status: COMPLETED

The Relation Between Triglyceride- Glucose Index, Procalcitonin and Cardiac Affection in Septic Shock.

NCT06518083 ·Status: NOT_YET_RECRUITING

Observational Study About the Use of Perfusion Index to Use Vasopressor in Sepsis

NCT06860438 ·Status: RECRUITING

Role of Early Point of Care Ultrasound in Management of Sepsis in Emergency Department

NCT05849194 ·Status: COMPLETED ·Phase: NA

Short-course Antimicrobial Therapy in Sepsis

NCT02899143 ·Status: UNKNOWN ·Phase: PHASE2

Ratio of ''Central Venous-to-Arterial Co2 Gap'' to ''Arterial-to-Central Venous O2 Content Gap'' in Septic Shock

NCT04425161 ·Status: UNKNOWN

Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)

NCT02803346 ·Status: UNKNOWN

Impact of 30 mg/kg Amikacin and 8 mg/kg Gentamicin on Serum Concentrations in Critically Ill Patients With Severe Sepsis

NCT02898961 ·Status: COMPLETED ·Phase: PHASE4

Fluid Intolerance Signals as Safety Limits to Prevent Fluid-induced Harm During Septic Shock Resuscitation

NCT06568744 ·Status: RECRUITING ·Phase: NA

Comparison of Sensitivity Between Presepsine and Lactate for the Diagnosis of Severe Sepsis.

NCT02300415 ·Status: UNKNOWN